compound tirzepatide shortage Resolved: What It Means for Your Weight Loss Journey 1 and GIP therapy FDA Zepbound shortage ends, impacts

This pre-filled pen is designed for convenient subcutaneous (under-the-skin) self-injection and is available in dose settings of 0.25mg and 0.5mg per injection

Product Highlights Triple-Receptor Technology Acts on GIP + GLP-1 + Glucagon receptors for advanced metabolic support Effective Weight Management Support Helps regulate appetite and prolong satiety Glucose & Insulin Support Supports healthy glucose metabolism and insulin sensitivity Lipid Profile Support Helps maintain healthy LDL cholesterol levels Energy & Body Composition Supports improved body composition and overall vitality Who Is It For BMI 30 (Obesity) Long-term weight management support BMI 27 + Type 2 Diabetes Metabolic support solution For Those Who Tried Other Methods Advanced option when traditional approaches are not enough Suggested Research Dosing Protocol Week 14: 2 mg once weekly Week 58: 4 mg once weekly Maintenance: 6 mg once weekly Optional increase to 8 mg based on individual response Adjustments depend on body weight, response, and goals

At Restore, we recommend an Infrared Sauna session followed by a Cryotherapy session

Axo-myelinic neurotransmission: a novel mode of cell signaling in the central nervous system

PD-1, programmed death-1

J Minim Invasive Gynecol 2009;16:142-148